APA (7th ed.) Citation

Wu, J., Zhou, Q., Zhou, H., & Lu, M. (2023). Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy. Pediatric Rheumatology, 21(1), 1. https://doi.org/10.1186/s12969-023-00916-6

Chicago Style (17th ed.) Citation

Wu, Jianqiang, Qing Zhou, Hua Zhou, and Meiping Lu. "Case Report: JAK1/2 Inhibition with Baricitinib in the Treatment of STING-associated Vasculopathy with Onset in Infancy." Pediatric Rheumatology 21, no. 1 (2023): 1. https://doi.org/10.1186/s12969-023-00916-6.

MLA (9th ed.) Citation

Wu, Jianqiang, et al. "Case Report: JAK1/2 Inhibition with Baricitinib in the Treatment of STING-associated Vasculopathy with Onset in Infancy." Pediatric Rheumatology, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12969-023-00916-6.